Machine Learning

A battery innovator just won a key DOE grant to tackle a decades-old nuclear problem. Their secret weapon? Tiny carbon spheres.

Samsung's 2026 AI TVs will be the first to feature a native Google Photos app, using exclusive AI tools to turn your memories into a cinematic experience.

Goodix's new GR5410 chip uses Bluetooth 6.1 and Channel Sounding to enable ultra-secure, high-precision digital car keys that can defeat relay attacks.

A major order for advanced semiconductor equipment will fuel a European firm's expansion, powering next-gen AI data centers and LiDAR systems.

As pharma moves beyond small molecules, a new integrated platform helps developers navigate the challenges of PROTACs, peptides, and antibody drugs.

In a market roiled by price wars, JA Solar's rise to No. 1 signals a new era of leadership defined by resilience, technology, and bankability.

A top phone maker is ditching physical sensors for AI software in 20+ models. Discover how this invisible tech revolution is changing smartphone design.

The cardiac device innovator adds seasoned sales and operations executives to prepare its novel cryoablation technology for the global market.

Tevogen's Dr. Ryan Saadi donates over $88,000 in company stock to a UN-recognized charity, bolstering educational programs for underserved children.

A new cell-free therapy for the fatal lung disease IPF is heading to clinical trials, thanks to a key manufacturing partnership. Here's what it means.

Ursa Space Systems has been selected for the MDA's $151B SHIELD contract, signaling a new era of AI-driven satellite intelligence for homeland defense.

With a star-studded 2026 lineup and rapid global expansion, Barco's advanced HDR Lightsteering technology is poised to become the new premium cinema standard.

Loyola Marymount University is expanding its EV charging with ChargePoint's AI platform and maintenance service, creating a reliable network for its community.

Alvotech and Teva's settlement with Regeneron for an Eylea biosimilar paves the way for a 2026 launch, promising increased competition and lower costs.

The VCT posts a marginal loss but shows second-half recovery, while navigating strategic exits and facing a pivotal shift in UK VCT tax policy.

Researchers at Kanazawa University have developed engineered nanoparticles that can reprogram rogue immune cells, offering a targeted therapy for autoimmune diseases.

With backing from AstraZeneca and Pfizer, Beijing’s Syneron Bio is using its AI-driven platform to develop novel drugs for cancer and chronic illness.

In a fierce biotech talent war, Senti Bio's new equity grant for a key hire signals a strategic push for its gene therapy pipeline amid market volatility.

A historic U.S. executive order reclassifies cannabis, opening the door for pharmaceutical products. One Canadian firm is already years ahead of the curve.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.